Donald Notman
Direttore Finanziario/CFO presso OCULAR THERAPEUTIX, INC.
Patrimonio netto: 445 535 $ in data 31/05/2024
Posizioni attive di Donald Notman
Società | Posizione | Inizio | Fine |
---|---|---|---|
OCULAR THERAPEUTIX, INC. | Contatto Relazioni con gli Investitori | 25/09/2017 | - |
Direttore Finanziario/CFO | 25/09/2017 | - | |
Comptroller/Controller/Auditor | 25/09/2017 | - |
Storia della carriera di Donald Notman
Precedenti posizioni note di Donald Notman
Società | Posizione | Inizio | Fine |
---|---|---|---|
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Direttore Finanziario/CFO | 01/05/2014 | 01/03/2017 |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Corporate Officer/Principal | - | - |
Formazione di Donald Notman
Middlebury College | Undergraduate Degree |
Tuck School of Business at Dartmouth | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Canada | 2 |
Posizioni
Director of Finance/CFO | 2 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
OCULAR THERAPEUTIX, INC. | Health Technology |
Aziende private | 2 |
---|---|
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Health Technology |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Finance |
- Borsa valori
- Insiders
- Donald Notman
- Esperienza